YONDELIS .05 mg/mL
Trabectedin · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Janssen Products, LP
Yondelis (trabectedin) is a prescription chemotherapy medication given by intravenous infusion that is used to treat certain types of cancer, including soft tissue sarcoma and ovarian cancer. It works as an alkylating drug, which means it damages cancer cell DNA to stop tumor growth.
Key Facts
- Brand Name
- YONDELIS
- Generic Name
- Trabectedin
- NDC Code (Product)
59676-610- Manufacturer
- Janssen Products, LP
- Strength
- .05 mg/mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA207953
- Drug Class
- Alkylating Drug [EPC]
- Marketing Start
- 10/23/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is YONDELIS used for?
Yondelis (trabectedin) is a prescription chemotherapy medication given by intravenous infusion that is used to treat certain types of cancer, including soft tissue sarcoma and ovarian cancer. It works as an alkylating drug, which means it damages cancer cell DNA to stop tumor growth.
Is YONDELIS a controlled substance?
YONDELIS is not classified as a controlled substance by the DEA.
What is the generic name for YONDELIS?
The generic name for YONDELIS is Trabectedin. There are no other listed brand versions of Trabectedin.
What is the NDC code for YONDELIS .05 mg/mL?
The NDC (National Drug Code) for YONDELIS .05 mg/mL is 59676-610, listed by Janssen Products, LP.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)